Human embryonic stem cell therapy for aplastic anemia.

Clin Case Rep

Nutech Mediworld New Delhi India.

Published: June 2017

Human embryonic stem cell (hESC) therapy is the potential therapeutic option for the treatment of patients with aplastic anemia (AA). The study showed a remarkable improvement in the AA patient subsequent to hESC administration. No adverse events occurred in the patient. hESC therapy is safe and effective for AA patients.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5458044PMC
http://dx.doi.org/10.1002/ccr3.950DOI Listing

Publication Analysis

Top Keywords

human embryonic
8
embryonic stem
8
stem cell
8
aplastic anemia
8
hesc therapy
8
cell therapy
4
therapy aplastic
4
anemia human
4
cell hesc
4
therapy potential
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!